- Exchange: Tel Aviv
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Biocancell Ltd+ Add to Watchlist
BICL:IT147.90 ILs 1.50 1.00%
As of 10:24:21 ET on 12/24/2014.
Company Profile for Biocancell Ltd (BICL)
BioCancell Ltd. is a biopharmaceutical company that develops targeted cancer therapy treatments for numerous types of cancer. The treatment is based on utilizing a target gene, such as the H19 gene, an oncofetal gene expressed at high levels in over 40 types of human cancer tissues, while existing at a nearly undetectable level in the surrounding normal tissues.
Key Executives for Biocancell Ltd (BICL)
|Aharon SchwartzChairman||Jonathan BurginChief Financial Officer|
|Avraham HochbergChief Scientist/Co-Founder||Patricia OhanaVP:Research & Development|
|Monique Ben-AmVP:Clinical Development|